Latest Content

Diagnosed with limited-stage small-cell lung cancer, Tammy shares how treatment progress and a mindset shift helped her find hope.

The 10-3 vote came during a discussion in which the limitations of TIL therapy, the only approved option for this group of patients, were raised repeatedly.

After two cancer diagnoses, one survivor reflects on fear, healing, and why moving beyond the "battle" metaphor brought a new perspective.

The FDA approved Pluvicto with hormone therapy for PSMA-positive metastatic prostate cancer, helping delay disease progression in patients.

Patients with advanced biliary tract cancer lived longer on Imfinzi (durvalumab) plus chemotherapy than on chemotherapy alone, according to four-year follow-up data from the phase 3 TOPAZ-1 trial.

Tafinlar plus Mekinist extended progression-free survival to 12.8 months vs. 3.7 months with placebo in BRAF V600E-positive thyroid cancer.

After surviving testicular cancer, one survivor shares how writing, faith, running and hope helped him heal and embrace a meaningful life after treatment.

Heather Prather shares her stage 4 non small cell lung cancer journey, finding hope, joy and support through the LiveLung community and cancer advocacy.

A simple balance exercise for cancer patients: the Drinking Bird. Learn how this single-leg move builds stability, strength, and confidence safely.

Patients with advanced stomach cancer lived longer on sonesitatug vedotin than on standard treatment, according to new trial results.

A pediatric oncologist explains what families should know after childhood cancer treatment, from long-term side effects to emotional recovery.

Serene Hesri was 25 when Hodgkin lymphoma was diagnosed. After relapsing, she enrolled in a clinical trial — and has been in remission for five years.

Sarah Velasquez, BSN, RN, OCN, of MD Anderson Cancer Center, goes above and beyond for her chronic lymphocytic leukemia patients through thorough communication and proactive advocacy.